(Q42547817)

2 November 2017

MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain (English)

1 reference

2 November 2017

1 reference

Kaur S

1

1 reference

2 November 2017

Ozer H

series ordinal

2

1 reference

2 November 2017

Starr M

series ordinal

3

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

European Journal of Pharmacology

2 November 2017

1 reference

2 November 2017

332

1 reference

2 November 2017

2

1 reference

2 November 2017

153-160

1 reference

The functional anatomy of basal ganglia disorders

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: tonic EMG activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

The neostriatal mosaic: multiple levels of compartmental organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Effect of GPi pallidotomy on motor function in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Catalepsy induced by SCH 23390 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

The role of excitatory amino acids in experimental models of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Regionally distinct N-methyl-D-aspartate receptors distinguished by quantitative autoradiography of [3H]MK-801 binding in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Role of the ventromedial nucleus of the thalamus in motor behaviour--I. Effects of focal injections of drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Intranigral but not intrastriatal microinjection of the NMDA antagonist MK-801 induces contralateral circling in the 6-OHDA rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

New medical and surgical treatments for Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901078-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(97)01078-9

1 reference

2 November 2017

1 reference